Clinical Trials List
Protocol NumberGNX1021-01
Not yet recruiting
2026-08-01 - 2029-12-31
Phase I
Not yet recruiting1
-
Trial Applicant
GEORGE CLINICAL ASIA PACIFIC LIMITED
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- Chih-Hung Hsu Division of Hematology & Oncology
- Kun-Huei Yeh Division of Hematology & Oncology
- 吳宗哲 Division of Hematology & Oncology
- 徐偉勛 Division of Hematology & Oncology
- 陳國興 Division of Hematology & Oncology
- 梁逸歆 Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
31 participants
-
Global
94-110 participants